LSF in the news

News - 2017

Recipients of the 2017 San Francisco Good Government Awards


San Francisco Human Services Agency: Taninha Ferreira, LSF 2017 Alumna,

Noel Panelo, LSF 2013 Alumnus and Leo O’Farrell, LSF 2010 Alumnus



Dhaya, LSF alumna, MIT graduate and former venture capatialist was recently voted Best Comedian 2013 in SF Bay Guardian's Best of the Bay Readers Poll. She will be opening for Greg Proops at the San Francisco Punchline in August.

Photo: Dhaya Lakshminarayanan (2010).



"Trailblazer forges path for workplace equality" by Meredith May

The Chronicle, Monday, July 7, 2014

Selisse Berry is founder and CEO of a nonprofit dedicated to LGBT employee rights. Photo: Michael Short, The Chronicle


RITCH K. EICH, PhD - LSF 2002 Alumnus




News - 2012

NEIL GUILIANO - LSF 2012 Alumnus

Neil Giuliano, former Tempe, AZ mayor (first openly gay mayor of a major city) former GLAAD President, and current CEO of San Francisco AIDS Foundation, reads from The Campaign Within, his new book about his journey from closeted Republican Mayor, to national LGBT activist and Democrat. Brave and compelling, The Campaign Within demonstrates that the greatest campaigns are not the ones taking place within the public realms of electoral politics but the personal ones inside each and every one of us.

More About Neil Giuliano
Neil G. Giuliano is an educator, activist, philanthropy advisor, leadership coach, and speaker. A former mayor and president of a national advocacy organization, he has been involved with community service and public affairs his entire career.


RITCH K. EICH, PhD - LSF 2002 Alumnus


Proceeds from the sale of this book are being donated to nonprofit organizations helping U.S. military men and women wounded in Iraq or Afghanistan.


NEWS - 2011

JAY CUETARA (1962-2013) - LSF Class of 1999

Remembering Jay with appreciation for fifteen years of contributions to LSF, including hundreds of volunteer hours.

10/31/11 - The White House - Office of the Press Secretary

Oval Office  

12:50 P.M. EDT
     THE PRESIDENT:  Well, thank you all for being here.  
     The United States, I think rightly, takes pride on having the most innovative and most successful drug industry in the world, and as a consequence the health of a lot of people, both here in the United States and around the world, is actively promoted.  But as we also know, occasionally there are problems in our manufacture and distribution of drugs and how accessible they are to people.  
     And recently, we have seen how the potential of drug shortages for vital drugs, including some cancers, can really have a adverse impact on patients and those who are caring for patients.  Sometimes we run out of or run low on certain types of drugs, and that drives up prices and it increases patient risk.
     And I've got a couple of people here beside me who have had to navigate this problem.  Jay Cuetara knows what it's like.  In August, the center where he was receiving chemotherapy ran out of the drug being used to treat his cancer.  And when that happens, you have pharmacy managers like Bonnie Frawley who have to scramble to make sure that their patients can somehow find the lifesaving medications that are necessary.
     So over the last five years, the number of these drug shortages has nearly tripled.  And even though the FDA has successfully prevented an actual crisis, this is one of those slow-rolling problems that could end up resulting in disaster for patients and health care facilities all across the country.  
     Congress has been trying since February to do something about this.  It has not yet been able to get it done.  And it is the belief of this administration, as well as folks like Bonnie and Jay, that we can't wait for action on the Hill -- we've got to go ahead and move forward.
     So, as a consequence, I'm going to be signing an executive order today that directs the FDA to step up work to reduce the drug shortages and protect consumers.  We'll still be calling on Congress to pass a bipartisan bill that will provide additional tools to the FDA and others that can make a difference.  But until they act, we will go ahead and move.
     As part of this, we're going to require that drug companies let us know earlier about the potential for drug shortages so that we can respond successfully.  We're going to make sure that if we find out that prices are being driven up because shortages are being made worse by manipulations of companies or distributors, that we are making sure that we stop those practices.  We're going to further empower the FDA and the Department of Justice to investigate any kinds of abuses that would lead to drug shortages.
     So there's a combination of tools that are going to be contained in this executive order that can make sure that lifesaving drugs are available, and if we start seeing shortages, that we're able to catch those ahead of time so that Bonnie doesn't have to try to scramble as a pharmacy manager, and Jay, obviously, doesn't have to scramble as a patient.  
     This is something that needs to be done.  I want to thank the leadership of both our FDA Administrator and our Health and Human Services Secretary for having done outstanding work in preparing this executive order.  And again, I still urge Congress to move forward and build on this executive order so that we can provide even more tools for our agencies.  And I want to thank Bonnie and Jay for being here and for helping inspire us to get this done.
All right.  With that I'm going to sign this bill -- or this executive order -- excuse me.
(The executive order is signed.)
There you go.  Thank you very much, everybody.  Appreciate it.
Q:    Tony Blair -- can you tell us anything about the meeting with Tony Blair this morning?
THE PRESIDENT:  I enjoyed our meeting with Tony Blair.  
Thank you, guys.

12:55 P.M. EDT


NEWS - 2007

LARRY BAER and LYNN B. BUNIM - LSF 1988 Alumni

  • 8/9/2007 San Francisco Chronicle

    Leah Garchik’s column.

    “You could sort of feel it coming,” said Lynn Bunim, who as executive director of
    external affairs at AT&T had been given tickets to Tuesday’s ball game a few months ago. “…And when he came up the third time, there was this spontaneous eruption of 'Barry, Barry.’ And into that noise, he hit this ball and it went sailing. It was spectacular.”

    Bunim had a special connection to the Giants, the game and especially the ballpark. She and Giants exec Larry Baer were in San Francisco Chamber of Commerce’s leadership program back in 1988. A few years later, before the new ballpark was approved and the Giants were quietly making contacts in the corporate community, Baer called her. “He told me what the proposition was, I got hold of our chairman and CEO, and connected him with Peter Magowan. …Once that connection was made, the deal was sewn up.” In December 1995, they agreed that if the ballot measure passed to build the ballpark, her company would have the naming rights for 20 years. It was a result of networking, and “it really was about the S.F. Chamber leadership program that led to Larry and me meeting, putting CEO’s together very quietly and sealing the deal.”

    Bunim’s family has had a long baseball connection. Her father’s business, Haas Brothers, had a box on the first-base line at Seals Stadium and then at Candlestick. “I grew up with baseball, with McCovey and Cepeda. I grew up with baseball, on first base. When Barry said, ‘My dad,’ it just got to me personally because my dad was there, too.”



Leadership San Francisco is an affiliate of the San Francisco Chamber of Commerce Foundation
copyright 2007 Leadership San Francisco

"Although my knowledge of the challenges that San Francisco faces was enhanced significantly by my participation with LSF, it has been my interaction with the many talented and capable people I have met through LSF that has had an even greater impact." - James E. Canales, President & CEO, The James Irvine Foundation. LSF 1992.